Association between sodium-glucose cotransporter-2 inhibitors and incident atrial fibrillation/atrial flutter in heart failure patients with reduced ejection fraction: a meta-analysis of randomized controlled trials.

MLA

Sfairopoulos, Dimitrios, et al. “Association between Sodium-Glucose Cotransporter-2 Inhibitors and Incident Atrial Fibrillation/Atrial Flutter in Heart Failure Patients with Reduced Ejection Fraction: A Meta-Analysis of Randomized Controlled Trials.” Heart Failure Reviews, vol. 28, no. 4, July 2023, pp. 925–36. EBSCOhost, https://doi.org/10.1007/s10741-022-10281-3.

APA

Sfairopoulos, D., Liu, T., Zhang, N., Tse, G., Bazoukis, G., Letsas, K., Goudis, C., Milionis, H., Vrettos, A., & Korantzopoulos, P. (2023). Association between sodium-glucose cotransporter-2 inhibitors and incident atrial fibrillation/atrial flutter in heart failure patients with reduced ejection fraction: a meta-analysis of randomized controlled trials. Heart Failure Reviews, 28(4), 925–936. https://doi.org/10.1007/s10741-022-10281-3

Chicago

Sfairopoulos, Dimitrios, Tong Liu, Nan Zhang, Gary Tse, George Bazoukis, Konstantinos Letsas, Christos Goudis, Haralampos Milionis, Apostolos Vrettos, and Panagiotis Korantzopoulos. 2023. “Association between Sodium-Glucose Cotransporter-2 Inhibitors and Incident Atrial Fibrillation/Atrial Flutter in Heart Failure Patients with Reduced Ejection Fraction: A Meta-Analysis of Randomized Controlled Trials.” Heart Failure Reviews 28 (4): 925–36. doi:10.1007/s10741-022-10281-3.